Skip to main content

$0.025 (0%)

High

$0.03

Low

$0.02

Trades

21

Turnover

$24,266

Volume

981,823
30 June 2023 at 3:59pm
Register to track PCK and receive email alerts.
Subject
PCK Ann: Quarterly Update and Appendix 4C

PCK Ann: Initial Director's Interest Notice

PCK Ann: Appointment of Non Executive Director

PCK Ann: Summerset Holdings Ltd rolls out PainChek in NZ

PCK Ann: Appendix 4D and Half Year Report

PCK Ann: Supplementary Appendix 4C Announcement

PCK Ann: Quarterly Update Investor Webinar 31 January

PCK Ann: Quarterly Update Investor Presentation

PCK Ann: Quarterly Update and Appendix 4C

PCK Ann: PCK enters home care mkt in collaboration with MPS Connect

PCK Ann: Clarification to Appendix 4C

PCK Ann: Results of AGM

PCK Ann: Response to ASX Price and Volume Query

PCK Ann: PainChek AGM Investor Update

PCK Ann: Virtual healthcare day presentation

PCK Ann: Correction to AGM Notice of Meeting

PCK Ann: Notice of Annual General Meeting/Proxy Form

PCK Ann: September Quarterly Update

PCK Ann: Appendix 4C Cash Flow Report

PCK Ann: Appendix 4G and Corporate Governance Statement

PCK Ann: Annual Report 2021

PCK Ann: Change of Director's Interest Notice x 4

PCK Ann: Notification regarding unquoted securities - PCK

PCK Ann: PainChek Infant study published in Lancet Digital Health

PCK Ann: Full Year Statutory Accounts

PCK Ann: Preliminary Final Report

PCK Ann: Taxation Assessment

PCK Ann: Cleansing Statement

PCK Ann: Application for quotation of securities - PCK

PCK Ann: Painchek to present at NWR Virtual Investor Conference

PCK Ann: Quarterly Update June 2021

PCK Ann: Appendix 4C

PCK Ann: PainChek to receive $1.25M milestone payment from DoH

PCK Ann: PainChek achieves 127,000 licensed RAC beds in Australia

PCK Ann: Change of Company Secretary

PCK Ann: PainChek Infant Achieves International Regulatory Clearances

PCK Ann: Appendix 3G

PCK Ann: March 2021 Quarterly Update

PCK Ann: Appendix 4C - quarterly

PCK Ann: PainChek receives CE Mark & TGA clearance for Universal App

PCK Ann: PainChek to present at NWR Virtual Investor Conference

PCK Ann: Appendix 3G

PCK Ann: S&P DJI Announces March 2021 Quarterly Rebalance

PCK Ann: Appendix 4D & Financial Statements

PCK Ann: Response to ASX Price Query

PCK Ann: Presentation - December 2020 Quarter Update

PCK Ann: December 2020 Quarterly Update

PCK Ann: Appendix 4C - quarterly

PCK Ann: Successful Completion of Infant Face-Only Clinical Study

PCK Ann: $979k R&D Tax Incentive Received

Register to track PCK and receive email alerts.

Similar Companies

4DX
ALC
CGS
IME
M7T
MDR
PKS
PME
RAP